IB 1001 (Inspiration Bio) filed at FDA for Haemophilia B - 19-Apr-2012
Inspiration Biopharmaceuticals has submitted a biologics license application (BLA) to the FDA for the approval of IB1001, an intravenous recombinant factor IX for the treatment and prevention of bleeding in Haemophilia B. Ipsen has European rights to the product.
Related News
Phase III trial for N9-GP(Novo Nordisk) treatment for Haemophilia B
FDA accepts BLA from Biogen for Eloctate for treatment of Haemophilia A
Biogen IDEC files rFVIII Fc at FDA for treatment of Haemophilia A
FDA expands approval of Corifact (CSL Behring) to manage surgical bleeding in adult and pediatric patients with Factor XIII Deficiency
Successful studies for rFVIIIFc and rFIXFc (Biogen/Swedish Orphan) for Haemopilia
BAX 855 enters Phase II/III study for Haemophilia
Biogen Idec files rFIXFc at FDA for treatment of Haemophilia B
Phase III results for BAX 326 (Baxter) for Haemophilia B
Related Haematology Information
Haematology Clinical Guidelines
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection
AidsinfoBritish HIV Association guidelines for the treatment of TB/HIV coinfection 2011
British HIV AssociationHaematology Clinical Trials
Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (DASAPOST)
Clinicaltrials.gov 27 February 2013A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of FG-4592 for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis
Clinical Trials Register.eu 05 February 2013Haematology Medical Journal Abstracts
PedsQL™ Sickle Cell Disease Module: Feasibility, Reliability, and Validity
Pediatric Blood & Cancer 25 February 2013Validation of Variants in SLC28A3 and UGT1A6 as Genetic Markers Predictive of Anthracycline-Induced Cardiotoxicity in Children
Pediatric Blood & Cancer 25 February 2013Haematology Medical Apps
The Oncologist
Free
ACP PIER Database - Hematology
£37.29
Related Haematology Drugs
- FEOSPAN SPANSULE CAPSULES
- HAEMOCTIN 250 / HAEMOCTIN 500
- RIENSO 30 MG/ML SOLUTION FOR INJECTION
- FANHDI 25 I.U./ML, 50 I.U./ML AND 100 I.U./ML
- TREDAPTIVE 1000 MG/20 MG MODIFIED RELEASE TABLETS
- OCTANATE 50IU/ML
- GALFER CAPSULES
- FERRIPROX 500 MG FILM-COATED TABLETS
- EPREX 2000, 4000 AND 10000 IU/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
- HAEMOCTIN 250 / HAEMOCTIN 500
- ALPHANINE
Advert for Healthcare Professionals only